Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China · Delayed Price · Currency is CNY 6.12
-0.24 (-3.77%)
May 21, 2026, 3:00 PM CST
SHA:603168 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -273.68 | -238.72 | -123.44 | 25.41 | 44.75 | 35.66 |
Depreciation & Amortization | 70.65 | 70.65 | 72.61 | 73.02 | 65.83 | 61.67 |
Other Amortization | 1.7 | 1.7 | 1.34 | 1.93 | 2.27 | 1.5 |
Loss (Gain) From Sale of Assets | -0.9 | -0.9 | -1.05 | 0.01 | -15.82 | 0.21 |
Asset Writedown & Restructuring Costs | 233.99 | 233.99 | 33.34 | 13.3 | 9.48 | - |
Loss (Gain) From Sale of Investments | -29.44 | -29.44 | 16.67 | -16.02 | 2.51 | -7.21 |
Provision & Write-off of Bad Debts | 4.98 | 4.98 | 1.17 | -3.09 | 4.32 | 1.72 |
Other Operating Activities | 40.46 | 23.94 | 12.4 | 5.52 | -5.96 | 2.75 |
Change in Accounts Receivable | 6.54 | 6.54 | -2.33 | -12.04 | 6.83 | -4.19 |
Change in Inventory | -18.62 | -18.62 | 5.05 | -25.32 | -0.15 | 4.11 |
Change in Accounts Payable | -9.96 | -9.96 | 9.09 | -7.72 | 1 | 4.55 |
Change in Other Net Operating Assets | -3.41 | -3.41 | 0.87 | -12.28 | - | - |
Operating Cash Flow | 26.49 | 44.93 | 25.67 | 41.49 | 115.72 | 100.78 |
Operating Cash Flow Growth | 59.37% | 75.01% | -38.13% | -64.14% | 14.82% | 128.58% |
Capital Expenditures | -107.25 | -94.15 | -128.11 | -219.8 | -148.69 | -153.44 |
Sale of Property, Plant & Equipment | 0.04 | 0.06 | 2.89 | 0.08 | 0.35 | 0.49 |
Cash Acquisitions | -6.65 | -6.65 | -6.65 | -51.66 | - | - |
Divestitures | 0.5 | 0.5 | - | - | - | - |
Investment in Securities | 30.28 | 25.28 | -63.8 | -83.99 | 103.89 | 295.24 |
Other Investing Activities | 0.77 | 6.7 | -139.99 | 9.48 | - | - |
Investing Cash Flow | -82.31 | -68.26 | -335.66 | -345.89 | -44.45 | 142.28 |
Long-Term Debt Issued | - | 209.4 | 185 | 153.73 | 48 | - |
Long-Term Debt Repaid | - | -141.04 | -108.08 | -30.39 | -55.22 | -5.93 |
Net Debt Issued (Repaid) | 37.34 | 68.36 | 76.92 | 123.34 | -7.22 | -5.93 |
Issuance of Common Stock | - | - | - | 27.92 | 314.6 | - |
Repurchase of Common Stock | -7.69 | -7.69 | -13.67 | - | - | - |
Common Dividends Paid | -7.93 | -7.94 | -14.53 | -16.25 | - | - |
Other Financing Activities | -2.09 | - | -11.61 | - | 7.88 | -205.39 |
Financing Cash Flow | 19.62 | 52.72 | 37.11 | 135.01 | 315.26 | -211.32 |
Net Cash Flow | -36.2 | 29.39 | -272.88 | -169.39 | 386.54 | 31.74 |
Free Cash Flow | -80.76 | -49.22 | -102.43 | -178.3 | -32.97 | -52.66 |
Free Cash Flow Margin | -17.57% | -10.64% | -21.17% | -27.64% | -6.00% | -8.36% |
Free Cash Flow Per Share | -0.23 | -0.13 | -0.27 | -0.49 | -0.10 | -0.16 |
Cash Income Tax Paid | 33.69 | 33.69 | 27.77 | 44.51 | 49.61 | 68.93 |
Levered Free Cash Flow | -87.75 | -64.18 | -91.22 | -80.36 | 84.68 | -350.93 |
Unlevered Free Cash Flow | -82.15 | -58.57 | -86.03 | -77.47 | 85.71 | -350.45 |
Change in Working Capital | -21.27 | -21.27 | 12.64 | -58.59 | 8.35 | 4.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.